For example, tumor cells in devil facial tumor disease (DFTD) are not recognized by the adaptive immune system of Tasmanian devils because the tumors do not express major histocompatibility complex molecules, thus introducing MHC-expressing DFTD cells could be a potential treatment for DFTD [1]. This evidence concerns the gene HLA-C and neoplasm.